180 related articles for article (PubMed ID: 16439081)
1. Activation of the mu-opiate receptor by Vitex agnus-castus methanol extracts: implication for its use in PMS.
Webster DE; Lu J; Chen SN; Farnsworth NR; Wang ZJ
J Ethnopharmacol; 2006 Jun; 106(2):216-21. PubMed ID: 16439081
[TBL] [Abstract][Full Text] [Related]
2. Black cohosh (Actaea racemosa, Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human mu opiate receptor.
Rhyu MR; Lu J; Webster DE; Fabricant DS; Farnsworth NR; Wang ZJ
J Agric Food Chem; 2006 Dec; 54(26):9852-7. PubMed ID: 17177511
[TBL] [Abstract][Full Text] [Related]
3. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
4. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.
Cerqueira RO; Frey BN; Leclerc E; Brietzke E
Arch Womens Ment Health; 2017 Dec; 20(6):713-719. PubMed ID: 29063202
[TBL] [Abstract][Full Text] [Related]
5. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
[TBL] [Abstract][Full Text] [Related]
6. Opioidergic mechanisms underlying the actions of Vitex agnus-castus L.
Webster DE; He Y; Chen SN; Pauli GF; Farnsworth NR; Wang ZJ
Biochem Pharmacol; 2011 Jan; 81(1):170-7. PubMed ID: 20854795
[TBL] [Abstract][Full Text] [Related]
7. Vitex agnus castus effects on hyperprolactinaemia.
Puglia LT; Lowry J; Tamagno G
Front Endocrinol (Lausanne); 2023; 14():1269781. PubMed ID: 38075075
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
10. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
11. Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist.
Guarna M; Bartolini A; Ghelardini C; Galeotti N; Bracci L; Stefano GB; Bianchi E
Brain Res Mol Brain Res; 2003 Nov; 119(1):100-10. PubMed ID: 14597234
[TBL] [Abstract][Full Text] [Related]
12. Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus.
Selley DE; Cao CC; Liu Q; Childers SR
Br J Pharmacol; 2000 Jul; 130(5):987-96. PubMed ID: 10882382
[TBL] [Abstract][Full Text] [Related]
13. [Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: our experience with Vitex agnus castus].
Ciotta L; Pagano I; Stracquadanio M; Di Leo S; Andò A; Formuso C
Minerva Ginecol; 2011 Jun; 63(3):237-45. PubMed ID: 21654609
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
Wallisch M; Nelson CS; Mulvaney JM; Hernandez HS; Smith SA; Olsen GD
Biochem Pharmacol; 2007 Jun; 73(11):1818-28. PubMed ID: 17343833
[TBL] [Abstract][Full Text] [Related]
15. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis.
Verkaik S; Kamperman AM; van Westrhenen R; Schulte PFJ
Am J Obstet Gynecol; 2017 Aug; 217(2):150-166. PubMed ID: 28237870
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
Selley DE; Liu Q; Childers SR
J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome.
Schellenberg R; Zimmermann C; Drewe J; Hoexter G; Zahner C
Phytomedicine; 2012 Nov; 19(14):1325-31. PubMed ID: 23022391
[TBL] [Abstract][Full Text] [Related]
18. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
19. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China.
He Z; Chen R; Zhou Y; Geng L; Zhang Z; Chen S; Yao Y; Lu J; Lin S
Maturitas; 2009 May; 63(1):99-103. PubMed ID: 19269753
[TBL] [Abstract][Full Text] [Related]
20. Chaste tree (Vitex agnus-castus)--pharmacology and clinical indications.
Wuttke W; Jarry H; Christoffel V; Spengler B; Seidlová-Wuttke D
Phytomedicine; 2003 May; 10(4):348-57. PubMed ID: 12809367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
